Venture Capital

Origis Energy: $415 Million Funding Package Closed

By Amit Chowdhry ● Jan 12, 2025

Origis Energy, one of America's leading renewable energy and decarbonization solution platforms, announced the closing of financing for the Swift Air Solar project in Ector County, Texas. The $415 million funding package includes construction, term debt, and tax equity financing from Natixis Corporate & Investment Banking (CIB) and Advantage Capital.

Grand Games: $30 Million (Series A) Raised To Accelerate Growth

By Amit Chowdhry ● Jan 12, 2025

Grand Games, a gaming studio behind the widely loved Magic Sort mobile game, announced it has raised a $30 million Series A round, marking its arrival as the latest up-and-coming studio to emerge from Istanbul, the gaming powerhouse that brought forth Dream Games and Peak Games. Balderton Capital led the round with participation from existing investors Bek Ventures (formerly known as Earlybird Digital East), Laton Ventures, and angel investor Mert Gür.

Prudentia Sciences: AI-Based Life Sciences Marketplace Company Raises $7 Million

By Amit Chowdhry ● Jan 12, 2025

Prudentia Sciences, an AI-based technology platform for life sciences announced its public launch, supported by $7 million in funding. This funding round was led by GV, with participation from Iaso Ventures and Virtue.

Tenvie Therapeutics Raises $200 Million For Delivering Small Molecule Therapies

By Amit Chowdhry ● Jan 12, 2025

Advanced Ionics: Green Hydrogen Electrolyzer Company Raises $6.7 Million

By Amit Chowdhry ● Jan 12, 2025

Advanced Ionics, a developer of a new class of green hydrogen electrolyzers aimed at accelerating decarbonization, announced that it raised an additional $6.7 million in funding from strategic investors JERA, Lummus Venture Capital, the Argosy Foundation, and existing investors Clean Energy Venture Group and bp Ventures.

Bonaccord Capital Partners: Fund II Closes At $1.6 Billion

By Amit Chowdhry ● Jan 12, 2025

Bonaccord Capital Partners - a private equity business focused on providing growth capital and strategic support to middle-market private markets sponsors - announced the final close of its second GP Stakes fund, Bonaccord Capital Partners II (BCP II), with $1.6 billion in total commitments.

Absci Raising $20 Million From AMD

By Amit Chowdhry ● Jan 12, 2025

Absci Corporation, a data-first generative AI-based drug creation company, announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to power critical AI drug discovery workloads, including Absci's advanced de novo antibody design models. And AMD will also make a $20 million investment in Absci, structured as a private investment in public equity (PIPE), highlighting the growing demand for innovative AI applications in drug discovery.

Vensana Capital: $425 Million Fund III Closed For Investing In Breakthrough Medical Technologies

By Amit Chowdhry ● Jan 12, 2025

Vensana Capital announced the closing of Vensana Capital III with $425 million in committed capital. This fund was oversubscribed at its hard cap with the support of the firm’s existing limited partners alongside select new institutional investors, and it brings Vensana’s total capital under management to about $1 billion.

Leyden Labs: $70 Million Secured For Advancing Intranasal Antibody Programs

By Amit Chowdhry ● Jan 12, 2025

Leyden Laboratories announced it has raised $70 million in funding to advance its Mucosal Protection Platform. This funding round was supported by co-leads ClavystBio and Polaris Partners, with participation by Qiming Venture Partners and existing investors. And the company’s syndicate of VC investors now includes GV (formerly Google Ventures), Casdin Capital, F-Prime Capital, ClavystBio, Polaris Partners, Qiming Venture Partners, Invus, Byers Capital / Brook Byers, Bluebird Ventures, and Softbank Vision Fund 2.

RyboDyn: $4 Million (Pre-Seed) Raised To Pioneer Development Of First-In-Class Immunotherapies

By Amit Chowdhry ● Jan 12, 2025

RyboDyn announced the discovery of a new proteome and the successful closing of a $4 million pre-seed financing round to advance its mission of targeting the dark proteome to develop novel immunotherapies. The funding round was co-led by Genedant Capital and SeaX Ventures, with significant participation from SOSV and Swell VC as part of the investment syndicate.

Kian Capital Buying Gardening E-Commerce Company Eden Brothers

By Amit Chowdhry ● Jan 11, 2025

Kian Capital Partners, a lower-middle-market-focused private investment firm, announced that in partnership with management, it completed the acquisition of Eden Brothers, an e-commerce retailer specializing in flower seeds and bulbs for gardening enthusiasts nationwide.

RheumaGen: Gene Therapy Company Raises $15 Million (Series A)

By Amit Chowdhry ● Jan 11, 2025

RheumaGen - a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases - announced the closing of a $15 million Series A financing co-led by SPRIM Global Investments and William Taylor Nominees.

R136 Ventures: Interview With Founder & Managing Partner Victor Orlovski About The Investment Company

By Amit Chowdhry ● Jan 11, 2025

R136 Ventures is a unique investment company dedicated to mid- and late-stage startups in the U.S., Israel, and Dubai. Pulse 2.0 interviewed R136 Ventures Founder and Managing Partner Victor Orlovski to learn more about the firm.